Pediatrics, Hematology-oncology
-
People
-
Administrative Positions
- Wagner, Lars Martin, Chief, Division of Hematology/Oncology
-
Primary Appointments
- Barfield, Raymond Carlton, Professor of Pediatrics
- Deel, Michael D, Assistant Professor of Pediatrics
- Falletta, John Matthew, Professor Emeritus of Pediatrics
- Kreissman, Susan Gail, Professor of Pediatrics
- Landi, Daniel Bryce, Assistant Professor of Pediatrics
- Linardic, Corinne Mary, Associate Professor of Pediatrics
- Pahl, Kristy, Assistant Professor of Pediatrics
- Rosoff, Philip Martin, Professor of Pediatrics
- Rothman, Jennifer Ann, Associate Professor of Pediatrics
- Schroeder, Kristin M., Assistant Professor of Pediatrics
- Sun, Jessica Muller, Assistant Professor of Pediatrics
- Van Mater, David Sinclaire, Assistant Professor of Pediatrics
- Wagner, Lars Martin, Professor of Pediatrics
-
Secondary Appointments
- Jordan, Megan, Medical Instructor in the Department of Pediatrics
- Mathey-Prevot, Bernard, Professor in Pediatrics
- Shah, Nirmish Ramesh, Assistant Professor in Pediatrics
- Strouse, John J., Associate Professor in the Department of Pediatrics
-
-
Administers Grant
- 2018 ALSF Million Mile Grant
- A Demonstration Of The Impact Of Psychosocial Multi-Resour
- A NOVEL ROLE FOR THE CRM1 NUCLEAR EXPORT RECEPTOR IN LEUKEMOGENESIS: MECHANISMS AND TARGETING
- A Novel Hippo-Notch axis controlling embryonal rhabdomyosarcoma tumorigenesis
- A Novel Mechanism for Drugs Targeting the CRM1 Nuclear Export Protein in Leukemia
- A Novel Role for the CRM1 in Pediatric Leukemias: Mechanisms and Targeting
- ALTE15N2 STUDY
- ANBL1531
- Acid Sphingomyelinase Activation in Apoptosis
- Apixiban for Pediatric VTE (B0661037)
- COG NCTN Study Chair Work Order
- COG WORK ORDER: (PROJECT: EVERYCHILD (APEC14B1) PCR - COG FOUNDATION
- COG WORK ORDER: (PROJECT: PEDIATRIC MATCH (APEC1621SC) PCR - COG FOUNDATION
- COG WORK ORDER: BIQSFP AALL1131
- COG Work Order AALL07P1--Millennium Pharmaceuticals, Inc.
- COG Work Order AAML: 1031--Millennium Pharmaceuticals, Inc.
- COG Work Order: AALL1131: Ph III Clofarabine in High Risk B ALL
- Collection And Storage Centers For Clinical Research...
- Continuation Of Pediatric Cohort Of The Cooperative Study
- Cyclophosphamide Resistance In Medulloblastoma
- DIV-NB-401
- Defining A Role for the CRM1 Nuclear Export Protein in Pediatric Leukemias
- Development of a Neuroblastoma Clinical Research Program
- Development of peptide vaccine for diffuse intrinsic pontine glioma
- Display Memoryn Of The Impact Of Psychosocial Multiresouce
- Dissecting the role of injury is sarcoma formation
- Dissecting the role of injury is sarcoma formation
- Dissection of H3.3-K27's role in radiation resistance in DIPG
- Effect Of Swainsonine On Human Bone Marrow Stem Cells Trea
- Effect Of Swainsonine On Human Bone Marrow Stem Cells Trea
- Eltrombopag for SAA
- Evaluation of Olig2 inhibitors in a genetically engineered mouse model of DIPG
- Examine KPT330 in Murine Leukemia Models
- Expansion of the AYA Oncology Initiative at Duke University
- Functional Dissection of the K27M Histone Mutation In Gliomagenesis
- Functional Dissection of the K27M Histone Mutation in Vivo
- Gamete Preservation in Males Receiving Gametotoxic Chemotherapy
- Genetically Engineered Mouse Models of Neuroblasotma: the Impact of Mxi1 and Mxi0 Loss.
- Gluathione Modulation Of Alkylators In Medulloblastoma
- Glutathione Modulation Of Alkylators In Medulloblastoma
- Hematology-Oncology Fellowship Program
- ICON 1
- Identification and validation of the PAX3-FOXO1 protein interactome
- Identifying novel drugs for the treatment of brainstem tumours by direct infusion into the brain
- Investigating co-activator TAZ as a regulator of PAX3-FOXO1, cancer cell stemness, and chemoresistance in fusion-positive rhabdomyosarcoma
- Investigating the role of the transcriptional coactivator TAZ in alveolar rhabdomyosarcoma
- Investigation Of Selected Patient Groups From The Cooperat
- Mechanisms of Leukemogenic Transformations by MLL-CALM
- Melphalan Cytotoxicity And Resistance In Medulloblastoma
- Molecular Modeling of Pediatric Skeletal Muscle Tumors
- NCI Community Oncology Research Program (NCORP) Research Base Grant
- NF1-OPG
- Neurobiology And Rational Therapy Of Human Medulloblasto
- Neurobiology And Rational Therapy Of Human Medulloblastoma
- PBTC-029
- PBTC-042 (Phase 1 of PD-0332991)
- PBTC-043
- PKD Natural Study
- PKD Registry AG348-C-008
- Pediatric Brain Tumor Consortium
- Pediatric Hydroxyurea Phase III Clinical Trial (Baby Hug): Follow-Up Observational Study II
- Pediatric Oncology Group
- Pediatric Oncology Group Studies
- Pediatric Oncology Group Studies
- Pediatric Oncology Group Studies
- Pediatric Oncology Group Studies
- Pediatric Oncology Group Studies
- Pediatric Oncology Group Studies
- Per Case Reimbursement : NIH National Clinical Trials Network (NCTN)
- Phase I Trial Of 06-Benzylguanine Plus Bcnu In Glioma
- Pratt Cares Program
- Pratt Cares Program
- Prophylactic Penicillin In Sickle Cell Disease
- Props Ii, Ancillary Nasopharyngeal Culture Study
- Regional differences in Central Nervous System Gliomagenesis
- Role of Exon 0 in the function of Mxi 0
- SEG101B221 (Phase 2)
- SELHEM: Phase I/II (KPT-330)
- SJMB12: A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
- STUDY CHAIR: NIH National Clinical Trials Network (NCTN) Grant
- St. Baldrick's Summer Fellow Grant
- St. Baldrick's Summer Fellow Grant
- St. Baldrick's Summer Fellows
- TCD With Transfusions Changing to Hydroxyurea (TWITCH) Closeout
- Targeting the Hippo pathway in Ras-driven rhabdomyosarcoma
- The impact of Mxi1 and Mxi0 on N-Myc function in neuroblastoma
- The role of H3K27M-induced aberrant PRC2 activity in brainstem gliomagenesis
- The role of MEST (mesoderm specific transcript) in rhabdomyosarcoma
- The role of MST1 in non-canonical Hippo signaling in rhabdomyosarcoma
- The secreted protein SFRP3 as a therapeutic target in rhabdomyosarcoma
- To Demonstrate The Value Of Newborn Screening For Hemoglob
- Transplant Centers For Clinical Research On
- Validating a mouse model of rhabdomyosarcoma
- Visual Field Outcomes in Pediatric Patients with NF1-associated Optic Pathway Gliomas
- Workload Intensity NIH National Clinical Trials Network (NCTN)